Project will identify most promising interventions and help providers tailor treatments Case Western Reserve University School of Medicine’s Gunnur Karakurt, PhD has been awarded a four-year, $1.3 million grant from the National Institutes of Health to identify effective treatments for intimate partner violence (IPV), and to develop a decision-making tool for care providers. The project […]Continue Reading ...
In what could serve as a model for tackling one of the nation’s top public health crises, a University of Massachusetts Amherst epidemiology researcher is teaming up with two Western Massachusetts sheriff’s offices to design, implement and study an opioid treatment program for jail detainees in Franklin and Hampshire counties. Funded with a $1.5 million […]Continue Reading ...
pitolisant Treatment for Narcolepsy Harmony Biosciences Announces File Acceptance Of Its New Drug Application For Pitolisant PLYMOUTH MEETING, PA, February 12, 2019 — Harmony Biosciences, LLC (Harmony), announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for its investigational product, pitolisant, and has granted Priority […]Continue Reading ...
entrectinib Treatment for Solid Tumors FDA Grants Priority Review to Genentech’s Personalized Medicine Entrectinib South San Francisco, CA — February 18, 2019 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s New Drug Applications (NDAs) and granted […]Continue Reading ...
Working with international partners, a MedUni Vienna research group has shown that imaging techniques carried out prior to treatment indicate the potential success of drug therapy in depressive patients. They showed that the activity of a region of the forebrain determines the potential success of treatment with antidepressants. This finding promises to significantly shorten treatment […]Continue Reading ...
Home News Professional HRQoL Scores Decrease With Treatment Line in Multiple Myeloma WEDNESDAY, Feb. 13, 2019 — For patients with multiple myeloma (MM), health-related quality of life (HRQoL) scores decrease with treatment line, according to a study published in the January issue of Clinical Lymphoma, Myeloma & Leukemia. Nicholas Despiégel, from Amgen France in Paris, […]Continue Reading ...
Treatment for Depression FDA Advisory Committee Recommends Approval of Spravato (esketamine) Nasal Spray for Adults with Treatment-Resistant Depression TITUSVILLE, N.J., February 12, 2019 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) Psychopharmacologic Drug Advisory Committee and Drug Safety and Risk Management Advisory Committee jointly […]Continue Reading ...
Feb 14 2019 Results of two clinical studies have added to evidence that blood-based liquid biopsies can accurately track lung cancer treatment responses by measuring circulating tumor DNA (ctDNA) during immunotherapy and related treatments. Credit: Cancer Research There is an unmet clinical need for real-time, noninvasive detection of tumor response to targeted and immune checkpoint […]Continue Reading ...
Patients with interstitial lung disease—a group of disorders causing progressive scarring of lung tissue—are often prescribed various medications that specifically target their disease and others that treat their symptoms. A new Respirology study found that patients often experience significant burden associated with the treatment and management of their illness, and some are at risk of […]Continue Reading ...
FDA Approves Esperoct (turoctocog alfa pegol, N8-GP) for Hemophilia A Bagsværd, Denmark, 19 February 2019 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application for Esperoct for the treatment of adults and children with hemophilia A. Esperoct is the brand name for turoctocog alfa pegol, […]Continue Reading ...
KENILWORTH, N.J.–(BUSINESS WIRE) February 19, 2019 –Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Keytruda, Merck’s anti-PD-1 therapy, for the adjuvant treatment of patients with melanoma with involvement of lymph node(s) following complete resection based on results from the […]Continue Reading ...
Women experiencing miscarriage should be offered a choice in the treatment they receive, argues a new study from the University of Warwick that compares all treatment options for the first time. Although national guidelines recommend trying to resolve an unsuccessful pregnancy naturally, the new analysis shows that this is only successful in 70% of cases, […]Continue Reading ...
Cervical cancer can be insidious. Changes to the cervix are often detected with a pap smear, but for those with limited access to health care, cervical and vaginal cancers can go unnoticed for years–silently growing, spreading and invading other organs–and by the time they’re detected, they may be so advanced that the patient’s prognosis is […]Continue Reading ...
(HealthDay)—For common birthmarks, doctors should abandon the traditional wait-and-see approach, a leading group of pediatricians says. Instead, physicians should try to identify those that could cause scarring or medical problems and begin immediate treatment, according to a new American Academy of Pediatrics guideline. Infantile hemangiomas are bright red or bruise-like birthmarks that appear shortly after […]Continue Reading ...
Credit: CC0 Public Domain Treating male infertility using a new IVF technique called PICSI, which is already offered in some private clinics, does not increase the likelihood of having a baby, according to the results of a randomised controlled trial. During the PICSI treatment, sperm were selected to fertilise eggs based on whether they could […]Continue Reading ...
- Biologist uses new grant to find ways to eliminate schistosomiasis
- Bag-mask ventilation to help patients breathe during intubation prevents complications
- AbbVie Announces New Drug Application Accepted for Priority Review by FDA for Upadacitinib for Treatment of Moderate to Severe Rheumatoid Arthritis
- Nature versus nurture and addiction
- New website connects researchers with data experts, resources | News Center
- Today’s Concerns About Drug Prices Echo The Past
- CT and Doppler equipment have low accuracy in detecting cerebral vasospasm and ischemia
- Study finds out similarity in function between healthy retina cell and tumor cell
- CWRU awarded NIH grant to identify effective treatments for intimate partner violence
- Oncotype DX Not Cost-Effective for Low-Risk Breast Cancer
- Scientists discover new type of immune cells that are essential for forming heart valves
- Talk About Déjà Vu: Senators Set To Re-Enact Drug Price Hearing Of 60 Years Ago
- Genetic defect linked to pediatric liver disease identified
- New cellular atlas could provide a deeper insight into blinding diseases
- Growing number of cancer survivors, fewer providers point to challenge in meeting care needs
- Innovative compound offers a new therapeutic approach to treat multiple sclerosis
- $1.5 million grant to develop opioid treatment program for jail detainees
- FDA’s new proposed rule would update regulatory requirements for sunscreen products in the U.S
- Most Hip, Knee Replacements Last Decades, Study Finds
- Wellness problems prevalent among ob-gyn residents